HPGC Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation - PE Ratioverified

600829.SS

Price:

$9.96

Market Cap:

$5.78B

HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1994-02-24

Stock Exchange

SHH

Ticker

600829.SS

The PE Ratio as of September 2026 (TTM) for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is 42.33

According to HPGC Renmintongtai Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 42.33. This represents a change of 2.31% compared to the average of 41.37 of the last 4 quarters.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Historical PE Ratio (quarterly & annually)

How has 600829.SS PE Ratio performed in the past?

The mean historical PE Ratio of HPGC Renmintongtai Pharmaceutical Corporation over the last ten years is 23.54. The current 42.33 PE Ratio has changed 17.88% with respect to the historical average. Over the past ten years (40 quarters), 600829.SS's PE Ratio was at its highest in in the December 2020 quarter at 240.91. The PE Ratio was at its lowest in in the June 2021 quarter at 8.72.

Quarterly (TTM)
Annual

Average

23.54

Median

18.06

Minimum

13.09

Maximum

47.00

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of HPGC Renmintongtai Pharmaceutical Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 131.87%

Maximum Annual PE Ratio = 47.00

Minimum Annual Increase = -52.94%

Minimum Annual PE Ratio = 13.09

Quarterly (TTM)
Annual
YearPE RatioChange
202547.00131.87%
202420.2727.97%
202315.8414.21%
202213.87-0.93%
202114.00-52.83%
202029.68100.19%
201914.8313.25%
201813.09-52.94%
201727.82-28.62%
201638.97-43.34%

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Average PE Ratio

How has 600829.SS PE Ratio performed in the past?

The current PE Ratio of HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

27.70

5-year avg

22.20

10-year avg

23.54

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) PE Ratio vs. Peers

How is 600829.SS’s PE Ratio compared to its peers?

HPGC Renmintongtai Pharmaceutical Corporation’s PE Ratio is less than Ningbo Menovo Pharmaceutical Co., Ltd. (55.64), less than Fuan Pharmaceutical (Group) Co., Ltd. (85.13), greater than Hunan Fangsheng Pharmaceutical Co., Ltd. (14.32), less than Jinhe Biotechnology Co. Ltd. (238.70), greater than Tianjin Lisheng Pharmaceutical Co.,Ltd. (24.46), greater than Tibet Weixinkang Medicine Co., Ltd. (20.45), greater than Yabao Pharmaceutical Group Co., Ltd (15.08), greater than Beijing Beilu Pharmaceutical Co., Ltd (33.94), less than Teyi Pharmaceutical Group Co.,Ltd (66.32), less than LanZhou Foci Pharmaceutical Co.,Ltd. (76.56),

Build a custom stock screener for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HPGC Renmintongtai Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HPGC Renmintongtai Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is HPGC Renmintongtai Pharmaceutical Corporation's PE Ratio?

How is the PE Ratio calculated for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)?

What is the highest PE Ratio for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)?

What is the 3-year average PE Ratio for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)?

What is the 5-year average PE Ratio for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)?

How does the current PE Ratio for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) compare to its historical average?